Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Relationship of Pax6 activity levels to the extent of eye development in the mouse, Mus musculus.

Favor J, Gloeckner CJ, Neuhäuser-Klaus A, Pretsch W, Sandulache R, Saule S, Zaus I.

Genetics. 2008 Jul;179(3):1345-55. doi: 10.1534/genetics.108.088591. Epub 2008 Jun 18.

2.

Novel allele of crybb2 in the mouse and its expression in the brain.

Ganguly K, Favor J, Neuhäuser-Klaus A, Sandulache R, Puk O, Beckers J, Horsch M, Schädler S, Vogt Weisenhorn D, Wurst W, Graw J.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1533-41. doi: 10.1167/iovs.07-0788.

PMID:
18385073
4.

The novel mouse microphthalmia mutations Mitfmi-enu5 and Mitfmi-bcc2 produce dominant negative Mitf proteins.

Hansdottir AG, Pálsdóttir K, Favor J, Neuhäuser-Klaus A, Fuchs H, de Angelis MH, Steingrímsson E.

Genomics. 2004 May;83(5):932-5.

PMID:
15081122
5.

Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse.

Graw J, Neuhäuser-Klaus A, Klopp N, Selby PB, Löster J, Favor J.

Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1202-13.

PMID:
15037589
6.

Electroretinography as a screening method for mutations causing retinal dysfunction in mice.

Dalke C, Löster J, Fuchs H, Gailus-Durner V, Soewarto D, Favor J, Neuhäuser-Klaus A, Pretsch W, Gekeler F, Shinoda K, Zrenner E, Meitinger T, Hrabé de Angelis M, Graw J.

Invest Ophthalmol Vis Sci. 2004 Feb;45(2):601-9.

PMID:
14744904
7.

Crygf(Rop): the first mutation in the Crygf gene causing a unique radial lens opacity.

Graw J, Klopp N, Neuhäuser-Klaus A, Favor J, Löster J.

Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2998-3002.

PMID:
12202521
9.
10.

A 6-bp deletion in the Crygc gene leading to a nuclear and radial cataract in the mouse.

Graw J, Neuhäuser-Klaus A, Löster J, Favor J.

Invest Ophthalmol Vis Sci. 2002 Jan;43(1):236-40.

PMID:
11773036
11.

A 76-bp deletion in the Mip gene causes autosomal dominant cataract in Hfi mice.

Sidjanin DJ, Parker-Wilson DM, Neuhäuser-Klaus A, Pretsch W, Favor J, Deen PM, Ohtaka-Maruyama C, Lu Y, Bragin A, Skach WR, Chepelinsky AB, Grimes PA, Stambolian DE.

Genomics. 2001 Jun 15;74(3):313-9.

PMID:
11414759
12.

Saturation mutagenesis for dominant eye morphological defects in the mouse Mus musculus.

Favor J, Neuhäuser-Klaus A.

Mamm Genome. 2000 Jul;11(7):520-5.

PMID:
10886015
13.

Effects of ENU dosage on mouse strains.

Justice MJ, Carpenter DA, Favor J, Neuhauser-Klaus A, Hrabé de Angelis M, Soewarto D, Moser A, Cordes S, Miller D, Chapman V, Weber JS, Rinchik EM, Hunsicker PR, Russell WL, Bode VC.

Mamm Genome. 2000 Jul;11(7):484-8.

PMID:
10886010
15.
16.

Induction of specific-locus and dominant lethal mutations in male mice by ifosfamide (Holoxan).

Ehling UH, Favor J, Neuhäuser-Klaus A, Adler ID.

Genet Res. 1998 Dec;72(3):177-83.

PMID:
10036972
17.

Three murine cataract mutants (Cat2) are defective in different gamma-crystallin genes.

Klopp N, Favor J, Löster J, Lutz RB, Neuhäuser-Klaus A, Prescott A, Pretsch W, Quinlan RA, Sandilands A, Vrensen GF, Graw J.

Genomics. 1998 Sep 1;52(2):152-8.

PMID:
9782080
18.

Abnormal eye development associated with Cat4a, a dominant mouse cataract mutation on chromosome 8.

Grimes PA, Koeberlein B, Favor J, Neuhäuser-Klaus A, Stambolian D.

Invest Ophthalmol Vis Sci. 1998 Sep;39(10):1863-9.

PMID:
9727409
19.

Mapping of the autosomal dominant cataract mutation (Coc) on mouse chromosome 16.

Sidjanin DJ, Grimes PA, Pretsch W, Neuhäuser-Klaus A, Favor J, Stambolian DE.

Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2502-7.

PMID:
9375568
20.
22.

The mouse Cat4 locus maps to chromosome 8 and mutants express lens-corneal adhesion.

Favor J, Grimes P, Neuhäuser-Klaus A, Pretsch W, Stambolian D.

Mamm Genome. 1997 Jun;8(6):403-6. Erratum in: Mamm Genome. 2008 May;19(5):378.

PMID:
9166583
23.
24.

Genetic mapping of a mouse ocular malformation locus, Tcm, to chromosome 4.

Zhou E, Grimes P, Favor J, Koeberlein B, Pretsch W, Neuhauser-Klaus A, Sidjanin D, Stambolian D.

Mamm Genome. 1997 Mar;8(3):178-81.

PMID:
9069117
25.

The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney.

Favor J, Sandulache R, Neuhäuser-Klaus A, Pretsch W, Chatterjee B, Senft E, Wurst W, Blanquet V, Grimes P, Spörle R, Schughart K.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13870-5.

26.

Molecular analysis of two new Steel mutations in mice shows a transversion or an insertion.

Graw J, Löster J, Neuhäuser-Klaus A, Pretsch W, Schmitt-John T.

Mamm Genome. 1996 Nov;7(11):843-6. No abstract available.

PMID:
8875893
27.
28.

Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice.

Adler ID, Cao J, Filser JG, Gassner P, Kessler W, Kliesch U, Neuhäuser-Klaus A, Nüsse M.

Mutat Res. 1994 Sep 1;309(2):307-14.

PMID:
7520990
31.

Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide.

Ehling UH, Neuhäuser-Klaus A.

Mutat Res. 1994 May 1;307(1):229-36.

PMID:
7513801
32.

Genetic mosaicism in the house mouse.

Favor J, Neuhäuser-Klaus A.

Annu Rev Genet. 1994;28:27-47. Review. No abstract available.

PMID:
7893127
33.

Reevaluation of the induction of specific-locus mutations in spermatogonia of the mouse by acrylamide.

Ehling UH, Neuhäuser-Klaus A.

Mutat Res. 1992 Nov;283(3):185-91. No abstract available.

PMID:
1383787
34.

Induction of specific-locus and dominant lethal mutations in male mice by 1-methyl-1-nitrosourea (MNU).

Ehling UH, Neuhäuser-Klaus A.

Mutat Res. 1991 Sep-Oct;250(1-2):447-56.

PMID:
1944358
36.

Induction of specific-locus and dominant lethal mutations in male mice by busulfan.

Ehling UH, Neuhäuser-Klaus A.

Mutat Res. 1991 Aug;249(2):285-92.

PMID:
2072971
37.

Mutagenic activity of 2-amino-N6-hydroxyadenine in the mouse spot test.

Neuhäuser-Klaus A.

Mutat Res. 1991 Aug;253(1):109-14.

PMID:
1714539
38.

Tpi-1 and Gapd are linked very closely on mouse chromosome 6.

Pretsch W, Neuhäuser-Klaus A, Merkle S.

Genet Res. 1991 Feb;57(1):37-40.

PMID:
2040452
39.

Diaplacental induction by ethylnitrosourea of tumours at the pial border of the central nervous system in (T X HT)F1 mice.

Schmahl W, Luz A, Leierseder-Bauer M, Neuhäuser-Klaus A.

Carcinogenesis. 1990 Aug;11(8):1313-22.

PMID:
2387017
40.

DNA adduct formation in mouse testis by ethylating agents: a comparison with germ-cell mutagenesis.

van Zeeland AA, de Groot A, Neuhäuser-Klaus A.

Mutat Res. 1990 Jul;231(1):55-62.

PMID:
2366776
41.

A dose-response analysis of ethylnitrosourea-induced recessive specific-locus mutations in treated spermatogonia of the mouse.

Favor J, Sund M, Neuhäuser-Klaus A, Ehling UH.

Mutat Res. 1990 Jul;231(1):47-54.

PMID:
2366775
42.
44.

Simultaneous induction of mutagenic and cancerogenic effects in T x HT mice with transplacental ethylnitrosourea treatment.

Schmahl W, Neuhäuser-Klaus A, Leierseder-Bauer M, Luz A.

Teratog Carcinog Mutagen. 1990;10(4):307-20.

PMID:
1980033
45.

The mutagenic effect of caprolactam in the spot test with (T x HT) F1 mouse embryos.

Neuhäuser-Klaus A, Lehmacher W.

Mutat Res. 1989 Nov;224(3):369-71.

PMID:
2811928
46.

Positive effect of caprolactam in the mammalian spot test: an overview.

Fahrig R, Neuhäuser-Klaus A.

Mutat Res. 1989 Nov;224(3):377-8. Review. No abstract available.

PMID:
2682233
47.

Induction of specific-locus mutations in male mice by ethyl methanesulfonate (EMS).

Ehling UH, Neuhäuser-Klaus A.

Mutat Res. 1989 Oct;227(2):91-5.

PMID:
2797047
48.

Induction of specific-locus and dominant lethal mutations in male mice by chlormethine.

Ehling UH, Neuhäuser-Klaus A.

Mutat Res. 1989 Oct;227(2):81-9.

PMID:
2797046
49.

Mutagenic and teratogenic effects of acrylamide in the mammalian spot test.

Neuhäuser-Klaus A, Schmahl W.

Mutat Res. 1989 Jul;226(3):157-62. No abstract available.

PMID:
2747730

Supplemental Content

Loading ...
Support Center